Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in India
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Chhatrapati Sambhajinagar, Delhi, Kolkata, Pune, Rishikesh
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727 · EU 2025-523555-66-00 - Phase 3Not yet taking people in IndiaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Chennai, Delhi, Gurgaon, Hyderabad, Kochi, Kolkata, New Delhi, Pune, Rohini, Thiruvananthapuram
- Age
- 18 years and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00